Librela clinical update: 4 years of clinical experience

One hour of FREE online CPD for BVNA Members*!

With thanks to the support from our event sponsor, Zoetis, we are delighted to be able to offer BVNA members free of charge access to this event.

*Non-members are welcome to join this webinar but tickets will be charged at £15.00.

Sign up before 4pm on the day to receive the Zoom invitation to join the webinar.

Kindly sponsored by:

Speaker: Jayne Clark, BVSc, BSc(Hons), GPCertSAM, MRCVS

Jayne graduated as a veterinary surgeon from the University of Liverpool in 2005. She worked as a small animal vet in clinical practice for 10 years covering both first opinion and emergency work, during which time she gained her general practitioners certificate in small animal medicine. She has been a veterinary consultant for Zoetis since 2020, more recently moving into the role of National Veterinary Manager for the pain portfolio. She has particular clinical interests in anaesthesia, analgesia and geriatric medicine and is passionate about improving the quality of life for dogs and cats through effective management of chronic conditions.

Lecture Synopsis:

Pharmacovigilance is based on continuous product monitoring post approval to build on the knowledge gained during clinical studies and understanding of a product’s safety and efficacy profile. This lecture will include an overview of the processes of pharmacovigilance including its benefits and limitations as well as an overview of the global pharmacovigilance data available for Librela¹, the first anti-Nerve Growth Factor monoclonal antibody for management of osteoarthritis pain.

1. Monteiro, B.P., Simon, A., Knesl, O., Mandello, K., Nederveld, S., Olby, N.J., Innes, J.F., Lascelles, B.D.X. (2025) Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela™). Frontiers Vet Sci. 2025;12

Learning Points:

1. Understand how a product safety profile is established and the process of pharmacovigilance
2. Understand how to report a suspected adverse reaction to a veterinary medication
3. To gain insight into the global pharmacovigilance and safety data for Librela

If you should have any questions, please do not hesitate to contact; cpd@bvna.co.uk

Cancellation Policy

BVNA CPD Courses and Events Cancellation Policy